Ralimetinib (LY2228820) dimesylate

Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.

Trivial name N/A
Catalog Number S1494
Molecular Formula C20H25ClN4O
CAS# 862507-23-1
SMILES CC(C)(C)C1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=C(C=CC=N3)Cl
Size 50mg
Supplier Page http://www.selleckchem.com/products/LY2228820.html
Additional Information https://file.selleck.cn/downloads/struct/LY2228820-chemical-structure-S1494.gif